002620.KS
Jeil Pharma Holdings Inc
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,650.00
+1.19%Margins
Gross margin
39.5%
EBITDA margin
-6.4%
EBIT margin
-0.7%
Net margin
1.4%
FCF margin
-0.3%
2.7%
Return on equity
0.9%
Return on assets
-0.8%
Return on invested capital
0.70x
Asset turnover
KRW 11.9B
Cash from operations
KRW 5.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026